[talolard]

>> We would love your help figuring out how to get past this bottleneck.

Can you restructure the strategy so that the business can operate with a low (initial) growth rate ? You might find success by partnering with regional public health officials, who would sponsor or subsidize real world advertisement.

I live in Europe and last time I was in NY the subway was full of public health billboards encouraging people to carry naxalone.

Maybe you can convince one official or non profit somewhere to subsidize those billboards for you. You're not only solving a personal problem for the addicted, your solving a societal problem. I imagine that if you can show efficacy in one or two pilot regions, you'll have an easy time partnering with other ones / raising money (maybe non vc) / funding acquisition yourself.

My $0.02, hope it helps and good luck, nice to see startups doing important things.

[mattangriffel]

Appreciate these thoughts talolard. I like the idea of partnering with local governments and non-profits, and would welcome any introductions or suggestions there. As you mentioned, most would want to see efficacy in a few pilot regions first, which is what we're currently working on.

[petra]

You're working on proving your process.

Do you have enough patients to do that ?

If you do, why do you seek growth? Isn't it better, in the long term, to prove yourself, build a stable foundation and a good reputation among clinicians and than scale ?